Antonio López-Serrano, Alba Voces, José Ramón Lorente, Francisco José Santonja, Angela Algarra, Patricia Latorre, Pablo Del Pozo, José María Paredes
{"title":"Artificial intelligence for dysplasia detection during surveillance colonoscopy in patients with ulcerative colitis: A cross-sectional, non-inferiority, diagnostic test comparison study.","authors":"Antonio López-Serrano, Alba Voces, José Ramón Lorente, Francisco José Santonja, Angela Algarra, Patricia Latorre, Pablo Del Pozo, José María Paredes","doi":"10.1016/j.gastrohep.2024.502210","DOIUrl":"10.1016/j.gastrohep.2024.502210","url":null,"abstract":"<p><strong>Background and study aim: </strong>High-definition virtual chromoendoscopy, along with targeted biopsies, is recommended for dysplasia surveillance in ulcerative colitis patients at risk for colorectal cancer. Computer-aided detection (CADe) systems aim to improve colonic adenoma detection, however their efficacy in detecting polyps and adenomas in this context remains unclear. This study evaluates the CADe Discovery™ system's effectiveness in detecting colonic dysplasia in ulcerative colitis patients at risk for colorectal cancer.</p><p><strong>Patients and methods: </strong>A prospective cross-sectional, non-inferiority, diagnostic test comparison study was conducted on ulcerative colitis patients undergoing colorectal cancer surveillance colonoscopy between January 2021 and April 2021. Patients underwent virtual chromoendoscopy (VCE) with iSCAN 1 and 3 with optical enhancement. One endoscopist, blinded to CADe Discovery™ system results, examined colon sections, while a second endoscopist concurrently reviewed CADe images. Suspicious areas detected by both techniques underwent resection. Proportions of dysplastic lesions and patients with dysplasia detected by VCE or CADe were calculated.</p><p><strong>Results: </strong>Fifty-two patients were included, and 48 lesions analyzed. VCE and CADe each detected 9 cases of dysplasia (21.4% and 20.0%, respectively; p=0.629) in 8 patients and 7 patients (15.4% vs. 13.5%, respectively; p=0.713). Sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy for dysplasia detection using VCE or CADe were 90% and 90%, 13% and 5%, 21% and 2%, 83% and 67%, and 29.2% and 22.9%, respectively.</p><p><strong>Conclusions: </strong>The CADe Discovery™ system shows similar diagnostic performance to VCE with iSCAN in detecting colonic dysplasia in ulcerative colitis patients at risk for colorectal cancer.</p>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana Lancho Muñoz, Patricia Abellán Alfocea, Eduardo Redondo Cerezo
{"title":"Gastric antral ectasia and diaphragmatic hernia: A rare cause of iron deficiency anemia.","authors":"Ana Lancho Muñoz, Patricia Abellán Alfocea, Eduardo Redondo Cerezo","doi":"10.1016/j.gastrohep.2024.502209","DOIUrl":"10.1016/j.gastrohep.2024.502209","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elena Pérez Campos, Paula Villegas Pelegrina, Isabel Moreno Moraleda, Matilde Amparo Nievas Soriano, Álvaro Hernández Martínez
{"title":"Colitis due to hypogammaglobulinemia: IBD-like, the great unknown.","authors":"Elena Pérez Campos, Paula Villegas Pelegrina, Isabel Moreno Moraleda, Matilde Amparo Nievas Soriano, Álvaro Hernández Martínez","doi":"10.1016/j.gastrohep.2024.502205","DOIUrl":"10.1016/j.gastrohep.2024.502205","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140903592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Camilla Gallo, Lorenzo Dioscoridi, Massimiliano Mutignani
{"title":"The Oakland score: When low specificity implies excessive costs and time consume.","authors":"Camilla Gallo, Lorenzo Dioscoridi, Massimiliano Mutignani","doi":"10.1016/j.gastrohep.2024.502204","DOIUrl":"10.1016/j.gastrohep.2024.502204","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antonietta Gerarda Gravina, Raffaele Pellegrino, Giovanna Palladino, Giuseppe Imperio, Andrea Ventura, Marina Cipullo, Annachiara Coppola, Alessandro Federico
{"title":"Profiling the patient with inflammatory bowel disease in the relationship between physical activity and partner/social network status: A post hoc patient-tailored analysis of the \"BE-FIT-IBD\" study.","authors":"Antonietta Gerarda Gravina, Raffaele Pellegrino, Giovanna Palladino, Giuseppe Imperio, Andrea Ventura, Marina Cipullo, Annachiara Coppola, Alessandro Federico","doi":"10.1016/j.gastrohep.2024.502203","DOIUrl":"10.1016/j.gastrohep.2024.502203","url":null,"abstract":"<p><strong>Introduction: </strong>Normal quality of life is an ultimate target in the therapeutic approach to inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC) in the context of which regular physical activity (PA) is often a chimeric parameter that is not standardized in terms of quality/quantity. The study aimed to profile a sample of IBD patients about the relationship between PA-partner status and social network support.</p><p><strong>Patients and methods: </strong>A post hoc analysis of the \"BE-FIT-IBD\" study was set up by stratifying the data of PA with that of partner status and the support that the patient's social network (i.e., relatives, friends) provided in inciting the patient to practice regular PA.</p><p><strong>Results: </strong>In the 219 patients included, there was a greater tendency for patients with stable partners to view the risk of reactivation/worsening of IBD as a barrier to conducting regular PA (p<0.0001). Single patients considered PA more as a protective factor (p=0.045). Patients without a PA-supporting social network retained IBD-related treatment as a PA barrier (p=0.016) and PA as a risk for IBD complications (p=0.01), with less confidence that PA could improve the course of IBD (p<0.001). Rectal syndrome was an IBD-related barrier more represented in patients with PA-deterring social network (p<0.0001).</p><p><strong>Conclusions: </strong>These factors are potential targets for recovering the IBD patient's adherence to regular PA.</p>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Edilmar Alvarado-Tapias, Douglas Maya-Miles, Agustin Albillos, Rocio Aller, Javier Ampuero, Raul J Andrade, Maria Arechederra, Patricia Aspichueta, Jesus M Banales, Ana Blas-García, Esther Caparros, Teresa Cardoso Delgado, Antonio Carrillo-Vico, Joan Claria, Francisco Javier Cubero, Alberto Díaz-Ruiz, Maite G Fernández-Barrena, Anabel Fernández-Iglesias, Sonia Fernández-Veledo, Ruben Francés, Rocío Gallego-Durán, Jordi Gracia-Sancho, Manuel Irimia, Sabela Lens, María Luz Martínez-Chantar, Beatriz Mínguez, Rocío Muñoz-Hernández, Rubén Nogueiras, Bruno Ramos-Molina, Mar Riveiro-Barciela, Manuel L Rodríguez-Perálvarez, Manuel Romero-Gómez, Guadalupe Sabio, Pau Sancho-Bru, Meritxell Ventura-Cots, Silvia Vidal, Manuel D Gahete
{"title":"Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH).","authors":"Edilmar Alvarado-Tapias, Douglas Maya-Miles, Agustin Albillos, Rocio Aller, Javier Ampuero, Raul J Andrade, Maria Arechederra, Patricia Aspichueta, Jesus M Banales, Ana Blas-García, Esther Caparros, Teresa Cardoso Delgado, Antonio Carrillo-Vico, Joan Claria, Francisco Javier Cubero, Alberto Díaz-Ruiz, Maite G Fernández-Barrena, Anabel Fernández-Iglesias, Sonia Fernández-Veledo, Ruben Francés, Rocío Gallego-Durán, Jordi Gracia-Sancho, Manuel Irimia, Sabela Lens, María Luz Martínez-Chantar, Beatriz Mínguez, Rocío Muñoz-Hernández, Rubén Nogueiras, Bruno Ramos-Molina, Mar Riveiro-Barciela, Manuel L Rodríguez-Perálvarez, Manuel Romero-Gómez, Guadalupe Sabio, Pau Sancho-Bru, Meritxell Ventura-Cots, Silvia Vidal, Manuel D Gahete","doi":"10.1016/j.gastrohep.2024.502207","DOIUrl":"10.1016/j.gastrohep.2024.502207","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daniel Aparicio López, María Teresa González-Nicolás Trébol, Nieves Sánchez Fuentes, Antonio Martínez Germán, María Victoria Duque Mallén
{"title":"Importance of the LARS Score and POLARS Score predictive scale in the ideal treatment of rectal cancer.","authors":"Daniel Aparicio López, María Teresa González-Nicolás Trébol, Nieves Sánchez Fuentes, Antonio Martínez Germán, María Victoria Duque Mallén","doi":"10.1016/j.gastrohep.2024.502191","DOIUrl":"10.1016/j.gastrohep.2024.502191","url":null,"abstract":"","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140903594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carmen Amor Costa, Cristina Suárez Ferrer, Laura García Ramírez, Eduardo Martín-Arranz, Joaquín Poza Cordón, José Luis Rueda García, María Sánchez Azofra, Irene González Diaz, Clara Amiama Roig, María Dolores Martín-Arranz
{"title":"Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease.","authors":"Carmen Amor Costa, Cristina Suárez Ferrer, Laura García Ramírez, Eduardo Martín-Arranz, Joaquín Poza Cordón, José Luis Rueda García, María Sánchez Azofra, Irene González Diaz, Clara Amiama Roig, María Dolores Martín-Arranz","doi":"10.1016/j.gastrohep.2024.502201","DOIUrl":"10.1016/j.gastrohep.2024.502201","url":null,"abstract":"<p><strong>Aims: </strong>The aim of the study is to evaluate the clinical and biochemical response of inflammatory bowel disease patients treated with vedolizumab, 16 weeks after transitioning from intravenous (iv) to subcutaneous (sc).</p><p><strong>Methods: </strong>An observational, prospective, single-center cohort study was performed. Patients with inflammatory bowel disease and maintenance treatment with vedolizumab, stable for at least 4 months, were offered to switch to sc formulation. At the same time of treatment administration a blood test was performed, with vedolizumab levels and fecal calprotectin.</p><p><strong>Results: </strong>Forty-three patients were included, 12 of them (27.9%) chose to transition to sc formulation. All included patients remained in remission during follow-up. At week 16 no significant differences were found in terms of calprotectin levels in patients on iv treatment (mean 146.6±SD 45.9) vs. sc (159.26±53.9) (p=0.9). Vedolizumab serum levels at week 16 were higher in the sc group (22,364.3±5141.6) vs. iv (11,425.9±1514.2) (p=0.009). At week 16, 9 (75%) of the patients in the sc group were highly satisfied with the medication and 11 (91.7%) considered it easy to administer. Four patients (12.9%) in the iv group and 2 (16.6%) in the sc group presented mild adverse effects. The 2 cases (100%) of the sc group the adverse event was local inflammation at the injection site.</p><p><strong>Conclusion: </strong>In our experience, vedolizumab sc is a convenient alternative to iv administration. Vedolizumab serum levels in patients who transitioned to sc were higher than iv formulation.</p>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease.","authors":"Carlos González-Muñoza, Cristina Gely, Jordi Gordillo, Margalida Calafat, Federico Bertoletti, Fiorella Cañete, Míriam Mañosa, Alberto López-Faba, Paola Torres, Eugeni Domènech, Esther Garcia-Planella","doi":"10.1016/j.gastrohep.2024.502193","DOIUrl":"10.1016/j.gastrohep.2024.502193","url":null,"abstract":"<p><strong>Introduction: </strong>In the treatment of inflammatory bowel disease (IBD), we have biologic therapies administered intravenously and subcutaneously. Recently, some drugs can be administered by either of these routes. The real impact that intravenous administration has on the perception of the disease and the personal and work life of the patient is unknown.</p><p><strong>Methods: </strong>All IBD patients receiving intravenous infliximab treatment for at least 6 months were anonymously invited to participate. They were provided with a specific structured questionnaire with visual analogue scales (0-10) at two reference centers in the Barcelona area.</p><p><strong>Results: </strong>A total of 90 patients with a median age of 45 years (36-56) and a median infliximab treatment duration of 48 months (24-84) were included. The visit and therapy with infliximab in the day hospital were globally well evaluated (9, IQR 7-10). 78% of patients combined day hospital stays with other activities (26% employment). The personal impact was generally low (4, IQR 0-5.8), but the patient's job was threatened in 43% of patients on intensified treatment.</p><p><strong>Conclusions: </strong>The intravenous administration of biologic drugs on an outpatient basis is highly satisfactory among IBD patients. The impact on the work sphere appears to be more pronounced than on the personal sphere, an aspect that should be considered in shared decision-making with the patient.</p>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}